bgImage
Antibody Analytics

The Collaborative immunology CRO

Enriching your team

logo

We can tell your molecule’s story

 

Our mission is to unlock discoveries and develop solutions for biopharmaceutical companies seeking to overcome substantial scientific challenges by providing data of outstanding quality

calendar.svg

Meet us in person at upcoming events

We’re so pleased to announce that in 2023 we’ll be exhibiting and presenting at two prestigious conferences: 

  • BIO Boston: 5-8th June 
  • Immuno-Oncology Summit Europe in London: 20-22nd June – stand 7

 

horn.svg

Our new revolutionary IndEx-2 system has launched

A transformational, inducible cell system that allows selection of the safest and most efficacious targeted therapies. IndEx-2 is an in vitro cell-based platform that provides inducible expression of any target antigen of interest (TAOI).

  • Safety: Gain information on the potential of “on target, off tumour effects” via precise control of TAOI expression to model physiological and pathological expression levels
  • Efficacy: Determine the antigen density activation threshold of targeted immunotherapies, including immune cell engagers, ADCs and engineered immune cell therapies

IndEx-2 is an effective tool that can be used to enhance a pre-clinical data package with information that offers a more comprehensive understanding of a targeted drug mechanism of action and functional profile. 

 

News

Read our latest news and browse our scientific resource articles

30.05.23
4 min read
Introducing IndEx-2: The New Solution for Measuring the Safety & Efficacy of Your Therapeutic

Our latest new development is the launch of our transformative inducible cell line development platform: IndEx-2.

29.05.23
7 min read
Celebrating One Year of the Antibody Analytics Discovery Centre with Discovery Week

The 29th of May – 2nd of June marks ‘Discovery Week’ here at Antibody Analytics. A chance for us to celebrate as a team and promote discovery throughout the wider industry. Since cutting the ribbon on the Discovery Centre in May 2022, we've achieved some amazing milestones, and we're excited to share them with you.

04.11.22
5 min read
Treg function, Treg suppression and your therapeutic candidate

Our Treg suppression assay formats are adaptable, using natural Tregs isolated from PBMCs, or induced Tregs expanded and differentiated from naïve CD4+ T cells.

21.10.22
7 min read
Treg suppression assays for testing immuno-oncology and auto-immunity drugs

Regulatory T cells (thymically and peripherally derived Treg) have critical roles in maintaining immune homeostasis and controlling aberrant/excessive responses to self and non-self antigens.